Investor's Business Daily on MSN
Here's why this colon cancer testing biotech is a mutual fund favorite
This biotech has a one-of-a-kind colon cancer blood test. Shares broke out of a base on recent news.
Colon cancer is on the rise in younger people, which is why testing guidelines recommend testing starting at 45 for those at average risk. To stop colon cancer, it’s important to know when and how to ...
Time for a rear-ality check. Colorectal cancer rates have been rising among adults younger than 50 since the 1990s, a troubling trend that has perplexed scientists. Because of the increase in cases, ...
SAN FRANCISCO, CA, UNITED STATES, January 8, 2026 /EINPresswire.com/ — New global initiative urges patients and clinicians to wait for biomarker testing results ...
Researchers at the University of California, Irvine have developed a 3D human colon model integrated with bioelectronics to aid in colorectal cancer research and drug discovery. The "3D in vivo ...
Individuals with two HNPCC-associated cancers a including synchronous and metachronous colorectal cancers or associated extracolonic cancers Individuals with colorectal cancer and a first-degree ...
Opinion: The American Cancer Society’s new guidelines for colon cancer are a major win for Marylanders, writes Dr. Eric ...
Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...
Add Yahoo as a preferred source to see more of our stories on Google. We are continuing our conversation about Colon Cancer, testing, and advancements in medical technology with Dr. Ryan Permumpail ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results